Pharmacology, Toxicology and Pharmaceutical Science
microRNA
100%
Lung Cancer
100%
Cisplatin
100%
Protein E6
100%
Chemotherapy
50%
Protein P53
50%
Neoplasm
50%
Human Papillomavirus Type 16
33%
Human Papillomavirus
16%
Uterine Cervix Cancer
16%
Tumor Growth
16%
Cell Viability
16%
Non Small Cell Lung Cancer
16%
Retrospective Study
16%
Chromatin Immunoprecipitation
16%
Luciferase
16%
Biochemistry, Genetics and Molecular Biology
MicroRNA
100%
Cisplatin
100%
Bcl-2
100%
Mir-184
100%
P53
42%
Promoter Region
28%
Human Papillomavirus Type 16
28%
Binding Affinity
14%
Messenger RNA
14%
Cell Survival
14%
Oncogene C Myc
14%
Real-Time Polymerase Chain Reaction
14%
Retrospective Study
14%
Wart Virus
14%
Chromatin Immunoprecipitation
14%
Cell Viability
14%
Inhibitory Concentration
14%
CDC25A
14%
Tumor Progression
14%
Cell Growth
14%
Luciferase
14%
MTT Assay
14%
Immunology and Microbiology
Bcl-2
100%
P53
50%
Promoter Region
33%
Human Papillomavirus Type 16
33%
Wart Virus
16%
Binding Affinity
16%
Real Time Polymerase Chain Reaction
16%
Oncogene C Myc
16%
Cell Viability
16%
Chromatin Immunoprecipitation
16%
Cell Survival
16%
Inhibitory Concentration
16%
Cell Growth
16%